Ukrainian Pharmaceutical Market Monthly. Key macroeconomic indicators, pharmaceutical market dynamics, healthcare news, regulatory updates, market and companies news

1. Ukrainian Pharmaceutical Market Monthly
Upharmacia
Macroeconomic Environment | Market & Companies News |
Regulatory Updates | Healthcare News
Issue: 08 2016
UPharma Consulting is a professional consulting company, operating in the Life Sciences sector. We deliver
best global practices in market knowledge, people management, marketing and strategy in the CIS/CEE.
UPharma Consulting
Kiev / www.upharma-c.com / mailbox@upharma-c.com / +380 (44) 232-11-42

2. Page 2
Ukrainian Pharmaceutical Market Monthly: August 2016
2015 2016
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul
MACROECONOMIC INDICATORS
Q3 Q4 Q1 Q2 Q3
GDP (US$ bn) 25.552 25.588 17.655
growth, % y-o-y -26% -17% 0.1% 1.3%
Export of Goods (US$ bn) 3.15 3.09 3.35 3.23 3.13 3.36 2.04 3.08 2.99 3.10 2.88 2.93 2.92
growth, % y-o-y -34% -22% -22% -23% -21% -11% -31% 3% -13% 1% -2% -5% -7%
Import of Goods (US$ bn) 2.98 3.88 3.24 3.22 3.07 3.12 2.23 2.68 3.35 3.05 2.69 2.87 3.09
growth, % y-o-y -34% -2% -30% - 27% -27% -32% -26% -6% 5% 7% 2% 4% 4%
Industrial Production Sales (US$ bn) 5.71 5.42 5.72 6.29 5.92 6.37 4.93 4.93 5.41 5.17 5.39 5.44 5.61
growth, % y-o-y -33% -23% -20% -21% -19% -17% -18% 8% -2% -12% -5% -6% -2%
Retail Turnover of Enterprises (US$ bn) 1.94 1.88 1.86 2.04 1.80 2.01 1.60 1.50 1.64 1.76 1.59 1.73 1.87
growth, % y-o-y -41% -32% -38% -31% -33% -29% -19% 4% 2% 6% -18% -6% -3%
Unemployment Rate (%) 1.6 1.6 1.5 1.5 1.6 1.9 1.9 1.9 1.7 1.6 1.6 1.5 1.4
Average Salary (US$) 202 194 199 207 193 223 180 174 187 191 198 214 217
OFFICIAL CURRENCY EXCHANGE RATE
UAH / USD 21.8 21.6 21.8 21.8 23.3 23.4 24.3 26.4 26.4 25.6 25.2 25.0 24.8
UAH / EUR 23.9 24.0 24.5 24.6 25.1 25.4 26.3 29.3 29.2 29.1 28.5 28.1 27.5
PHARMACEUTI CAL INDUSTRY INDICATORS
Export of Pharma Products (mio USD) 13.85 9.01 13.79 12.2 11.7 15.77 8.31 13.33 15.54 13.90 14.17 16.15 13.36
growth, % y-o-y -6% -54% -47% -37% -52% -28% -30% 11% 16% 3% 9% 5% -4%
Import of Pharma Products (mio USD) 106.5 93.3 121.1 147.1 141.3 142.1 103.7 145.0 125.1 130.0 110.4 132.1 133.1
growth, % y-o-y -47% -47% -31% -28% -24% -42% 15% 27% 21% 25% 31% 15% 25%
Pharma Retail Sales, values (mio USD) 172.6 177.1 193.2 206.3 196.6 212.3 198.9 176.0 187.3 178.1 177.6 174.8 175.4
growth, % y-o-y -32% -24% -28% -26% -20% -18% -17% -1% -5% -1% -8% -2% 2%
Pharma Retail Sales, volumes (mio units) 119.5 122.5 126.7 130.2 129.0 136.4 133.6 126.8 133.8 125.2 123.6 122.6 122.7
growth, % y-o-y -10% -8% -11% -5% -4% -5% 1% -12% -5% 2% -1% 4% 3%
WACP (USD) 1.48 1.45 1.52 1.58 1.52 1.56 1.49 1.39 1.40 1.42 1.44 1.43 1.43
growth, % y-o-y -23% -18% -19% -22% -18% -14% -23% -23% 13% 1% -2% -6% -3%
CPI of Ukraine 155.3 152.8 151.9 146.4 138.1 134.6 131.9 126.9 113.5 108.4 107.3 106.9 107.9
Pharmaceutical Products CPI 151.8 149.4 145.8 142.1 146.6 143.3 140.3 132.7 120.9 109.8 107.5 108.2 107.4
Local Companies share, values (%) 41.8 41.4 41.4 41.4 41.7 40.9 42.3 42.9 42.7 42.3 42.9 42.8 42.8
Local Companies share, volumes (%) 78.4 78.2 76.5 75.7 75.8 76.7 75.6 76.5 76.5 76.7 77.2 77.4 77.9
MACROECONOMIC ENVIRONMENT
Description of the indicators:
MACROECONOMIC INDICATORS
GDP (Gross Domestic Product) is an aggregate measure of production equal to the sum of the
gross values added of all resident, institutional units engaged in production (plus any taxes, and
minus any subsidies, on products not included in the value of their outputs) calculated in current
prices. Converted from UAH to USD in accordance with an average official NBU exchange
rate in the corresponding period. Hereinafter: excluding the temporarily occupied territory of
the Autonomous Republic of Crimea and City of Sevastopol, as well as the part of zone of the
antiterrorist operation. Source: State Statistics Service of Ukraine.
Export of Goods is a sale of goods by Ukrainian subjects of foreign economic activities to foreign
subjects of foreign economic activities (including non-cash payment) with or without exportation
of these goods through the customs border of Ukraine, including the re-export of goods. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Import of Goods is a purchase (including non-cash payment) of goods by Ukrainian subjects
of foreign economic activities in foreign subjects of economic activities with or without the
importation of these goods into the territory of Ukraine, including the purchase of goods for
domestic consumption by establishments and organizations of Ukraine located abroad. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Industrial Production Sales is the value of industrial goods, which are actually shipped in the
period, as indicated in documents decorated as the basis for calculating with the buyer (customer),
regardless of income payments for them. Converted from UAH to USD in accordance with an
average official NBU exchange rate in the corresponding period. Source: State Statistics Service
of Ukraine.
Retail Turnover of Enterprises is the value of consumer goods sold via retail trade and
restaurants to the population by all operating enterprises. It also includes direct retail sales by
industrial, transport and other non-trade enterprises. In addition, retail turnover includes retail
sales of food products to departments, organizations and enterprises to provide meals to the
people they serve (at sanatoria, children’s care institutions, hospitals, etc.). Reflected in current
prices. Converted from UAH to USD in accordance with an average official NBU exchange rate in
the corresponding period. Source: State Statistics Service of Ukraine.
Unemployment Rate is a ratio (percent) of the unemployed registered at the State Employment
Service to the average annual population of working age. Source: State Statistics Service of
Ukraine.
Average Salary is an average value of remuneration in cash and in kind paid to employees for
time worked or work done. Converted from UAH to USD in accordance with an average official
NBU exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Official Currency Exchange Rate is the rate established by the National Bank of Ukraine
under which Ukrainian national currency – UAH (Ukrainian hryvnia) will be exchanged for foreign
currency (USD or EUR). Calculated as average value in the corresponding period. Source: National
Bank of Ukraine.
PHARMACEUTICAL INDUSTRY INDICATORS
Export of Pharma Products is an export of goods related to the group “Pharmaceutical products”
under the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in
USD. Source: State Statistics Service of Ukraine.
Import of Pharma Products is an import of goods related to the group “Pharmaceutical products”
under the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in
USD. Source: State Statistics Service of Ukraine.
Pharma Retail Sales are retail sales of different product categories of “pharmacy basket” (drugs,
medical devices, cosmetics and food supplements) in values and volumes. Converted from UAH
to USD in accordance with an average official NBU exchange rate in the corresponding period.
Source: Morion.
WACP (Weighted average cost of a pack) is a ratio of pharma retail sales in values to pharma
retail sales in volumes.
CPI (Consumer price index) is an indicator of changes at the time of prices and tariffs for
commodities and services being purchased by the population for unproductive consumption
calculated to corresponding month of previous year. Source: State Statistics Service of Ukraine.
Pharma Products CPI is a Consumer price index of “Pharmaceutical products, medical products,
appliances and equipment” group calculated to corresponding month of previous year. Source:
State Statistics Service of Ukraine.
Local Companies Share is the share (percent) of sales related to Ukrainian companies in overall
pharma retail sales in values and volumes. Source: Morion
Table: Key Macroeconomic
Indicators in Ukraine
(July 2015-July 2016)

3. Page 3
Ukrainian Pharmaceutical Market Monthly: August 2016
KEY ECONOMIC EVENTS
»» In 2Q2016, GDP of Ukraine has grown 1.3% y-o-y after 0.1% y-o-y growth in 1Q2016. Ukrainian government
expects the economy to grow 2% in 2016, while the IMF projects 1.5% GDP growth.
»» In 1H2016, investment in fixed assets in Ukraine have grown 9.6% y-o-y.
»» In July, treasury residuals of Ukraine decreased 38.9% m-o-m to UAH 11.0 bn. In August 1, 2015, the
accumulations amounted UAH 33.3 bn.
»» Ukrainian government intends to submit the draft version of stated budged to the Parliament in Sept, the Prime
Minister said. The budget will be completely honest and realistic, he added.
»» Finance Ministry expects the IMF tranche in Sep, after the fully functioning launch of electronic declaration in
Ukraine since Sep 1. E-declaration is the main condition for the credit provision, the Minister said.
»» Ukraine and Indonesia agreed to start consultations on a free trade area, Ukrainian President said. Ukraine
could be a platform for Indonesian investors to reach the European market, he added.
»» Prime Minister of Ukraine announced the intention to create full-featured trade missions of Ukraine abroad.
»» In 1H2016, capital inflow to Ukraine amounted USD 2.9 bn, which is almost three times more than in 1H2015
(USD 1 bn), the Statistics Service Reported. The most investments came from Russia (USD 1.3 bn). 70% of
investments were allocated in financial sector.
»» In Jul, industrial output in Ukraine decreased 0.2% y-o-y, improving from 3.4% decline in Jun. The decrease was
in such core industries such machinery (-11.5% y-o-y) and mining (-0.4%), while the growth was in chemicals
(7.1%), utilities (6.3%) and metals (4.3%).
172.6
177.1
193.2
206.3
196.6
212.3
198.9
176.0
187.3
178.1 177.6 174.8 175.4
119.5
122.5
126.7
130.2
129.0
136.4
133.6
126.8
133.8
125.2
123.6 122.6 122.7
100
110
120
130
140
150
160
100
120
140
160
180
200
220
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul
Pharma Retail Sales
2015 2016
Volumes (mio units)
Values (mio USD)
13.9
9.0
13.8
12.2 11.7
15.8
8.3
13.3 15.5
13.9
14.2
16.1
13.4
106.6
93.3
122.2
147.1
141.3 142.1
103.7
145.0
125.1
130.0
110.4
132.1 133.1
0
20
40
60
80
100
120
140
160
0
4
8
12
16
20
24
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul
Ukraine's International Trade
in Pharma Production
2015 2016
Export
Import
5.71
5.43
5.72
6.29
5.92
6.37
4.93 4.93
5.41 5.17
5.39 5.44
5.61
1.94 1.88
1.86
2.04
1.80
2.01
1.60
1.50
1.64
1.76
1.59
1.73
1.87
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0
1
2
3
4
5
6
7
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul
Industrial Production Sales &
Retail Turnover of Enterprises Surplus
2015 2016
Retail turnover of enterprises
Industrial production sales
21.8 21.6 21.8 21.8
23.3 23.4 24.3
26.4 26.4 25.6 25.2 25.0 24.8
26.1 25.9 26.1
24.6 25.1 25.4 26.3
29.3 29.2 29.1 28.5 28.1 27.5
155.3
152.8 151.9
146.4 146.6
143.3 140.3
132.7
120.9
109.8 107.5 108.2 107.4
0
20
40
60
80
100
120
140
160
0
5
10
15
20
25
30
35
40
45
50
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul
2015 2016
vs. Consumer Price Index
Official Currency Exchange Rates
CPI of Ukraine
UAH / €
UAH / $

4. RECRUITING &
EXECUTIVE
SEARCH
We recruit pharma people in the
CIS region and focus on:
> Sales & Marketing
> Regulatory Affairs
> Quality Assurance
> Finances
> Operations
> Administration
We aim to be your trusted advisor
in People Management
Anastasiya MAXIMENKO
Partner, HR-Consulting
AMaximenko@upharma-c.com
+380 (44) 232-11-43
+380 (97) 953-68-14

5. Page 5
Ukrainian Pharmaceutical Market Monthly: August 2016
MARKET & COMPANIES NEWS
Farmak launched
antiepileptic drug
Ukrainian pharmaceutical
company Farmak expanded
its portfolio by launching
Organiya (pregabalin), which
affects nervous system to treat
neuropathic pain, epilepsy,
generalized anxiety disorder
and fibromyalgia. The drug
is produced in the form of
capsules. The company already
has two antiepileptic drugs:
Meditan (gabapentin) designed
for the treatment of partial
epileptic seizures and Epileptal
(lamotrigine) used in additional
therapy against epilepsy in
children.
Drugs for nervous system
provide about 13% of sales of
Farmak in values. In 1H2016, the
company retained first position on
Ukrainian pharmaceutical market
with USD 56.1 mio for 41.7 ths
packs sales.
Security Service
of Ukraine inspects
Indian pharma
companies
In late July, the Security
Service of Ukraine (SSU)
started the inspection of Indian
pharmaceutical companies, which
operate in Ukraine, the Indian
Pharmaceutical Manufacturers
Association (IPMA) reported. The
authority requested about 10 ths
pages of information regarding
the activities of Indian companies
in Ukraine and some products
produced by them. According
to the SSU, the information is
requested due to the reports on
side effects caused by Indian
drugs being revealed by the State
Expert Center of the MOH (SEC).
“The SEC didn’t informed about
the complete or temporary
prohibition of the medical use
of the drugs, the information
on which requested,” the IPMA
said. “The statement of the SSU
on the facts of numerous side
effects provoked by the drugs is
unapproved and seems to exceed
its authorities. Moreover, all
requested information is stored in
the state bodies of Ukraine.”
Notably, all Indian companies,
fallen under the inspection,
participated in public
procurement of drugs, carried by
the international organizations. In
March 2016, the MOH excluded
all drugs of Indian company Venus
Remedies from the procurement
list after the Ministry questioned
the efficacy of the company’s
drug proposed for the
procurement by Crown Agents.
Kusum Pharm plans
to double production
capacities by 2018
Ukrainian company Kusum Pharm
plans to start enlargement of its
plant in Sumy by the end of 2016
to double production capacity
at least 2 times, the General
Director of the company Rajeev
Gupta said. The company plans to
start the enlargement of storage
facilities in 2016; in 2017 it will
expand the administrative building
and in 2018 will start expanding
of production.
“The crisis created unique
opportunities for import
substitution and expansion
of Ukrainian industry,” Mr.
Gupta said. “Devaluation of the
National currency decreased the
solvency of the population and
import drugs became almost
inaccessible. Consequently, the
demand for local medicines
increased.”
Kusum Pharm’s plant started
operating in 2009. The
company’s portfolio includes
60 generic drugs, generally for
the treatment of patients with
cardio-vascular, gastrointestinal
and endocrine diseases.
Kusum Pharm plans to localize
production of drugs, which are
now imported from Indian plant
Kusum Healthcare (also part of
Kusum Group).
In 1H2016, Kusum Pharm was
14th company on Ukrainian drug
market by sales in values. In
2015, the company produced
787 ths packs of tablets, 2.4 mio
packs of syrups and suspensions
and 258 ths packs of sachets.
The company’s revenues in 2015
amounted UAH 822.1 mio.
Kreoma-Pharm
demands the
prohibition of
production of Enterosgel in Russia
Ukrainian company Kreoma-
Pharm appealed the Moscow
Arbitration Court with a lawsuit
against Russian company TNK
Silma. The claimant demands the
prohibition of manufacturing of
Enterosgel by Russian company
due to violation of patent law.
Enterosgel is an enterosorbent,
which is used for removing
harmful substances from
gastrointestinal tract.
In 2005, Kreoma-Pharm received
a Eurasian patent for an exclusive
right to an invention of the
preparation. TNK Silma claims it
had registered the similar patent
in Russia in 2004. Herewith,
both companies produce the
preparation under the license
of Swiss company Bioline
Pharmaceutical Ag.
Kenya may use
Ukrainian anti-
tuberculosis drugs
The government of Kenya

6. Page 6
Ukrainian Pharmaceutical Market Monthly: August 2016
REGULATORY UPDATES
The Draft Law #2386a-1 “On
amendments to certain Laws of
Ukraine on transplantation of
organs and other anatomic human
materials” will be submitted for
the second reading voting in
Oct 2016, the Member of the
Parliamentary Committee on
Public Health Olexiy Kyrychenko
said. The document allows organ
transplantation from dead citizens
of Ukraine and is based on the
presumption of disagreement.
The Draft Law was approved in
the first reading in Apr 2016 and
then was sent for revision.
The document is aimed to
update the existing Law “On
transplantation”. It envisages
the development of national
register of donors and recipients
and makes amendments to the
State budget. The Draft Law
is expected to create a brand
new transplantation system
in Ukraine. According to the
Deputy Kyrychenko, Members
of Parliament have already
submitted about 100 pages of
corrections to the document.
--
The Cabinet of Ministers of
Ukraine (CMU) approved the
Resolution #560 dated Aug 23,
which amends the Resolution
#787 dated Oct 8, 2015 and
allows specialized International
organizations to procure additional
amount of drugs for saved funds
from the State budget 2015.
Thus, International organizations
will have the opportunity to make
prompt decisions regarding the
use of residues of saved funds.
Lately, International organizations,
which conduct delegated public
procurement for Ukraine, said
they couldn’t carry additional
procurement of drugs as the
contracts with the MOH do not
provide the further use of saved
funds. Crown Agents reported
it had saved about 45% of UAH
500 mio, being allocated for drug
procurement under oncology
program. UNICEF also managed
to save USD 3.8 mio from
vaccines procurement.
--
In Aug, the MOH promulgated the
Draft Resolution “On approval of
the National strategy for blood
service development”, which
aims to ensure equal and timely
patient access to quality and
safe blood components in the
required amount. The document
is developed to execute the EU-
Ukraine Association agreement
in regard of cooperation
development in healthcare sphere.
The Draft National strategy
envisages the reform of blood
service towards decentralization
at regional level. The document
proposes to implement
multichannel system of blood
service funding as well as quality
control system. The main body,
which is to conduct management
and monitoring of blood service
programs, is the National
Transfusiological Center, which
should be developed under the
MOH. The strategy also includes
development of donor recruitment
program and program for donor
resource management.
At the same time, the National
strategy does not provide the
launch of the Single donor base
of Ukraine. The donor registers
will be kept by specialized
organizations and transfusion
institutions at the regional level.
considers the possibility to use
drugs produced by Ukrainian
companies to fight tuberculosis,
the Association of Ukrainian
drug producers reported. The
corresponding issues were
discussed during the meeting
between Ukrainian Ambassador
in Kenya with the Healthcare
Minister of Kenya.
During the meeting, the parties
discussed possible ways of
boosting bilateral relations in
healthcare sphere, development
of scientific and technological
cooperation and conclusion of the
Memorandum on intersectoral
cooperation between Ukraine
and Kenya. Ukrainian diplomat
familiarized Kenyan Minister
with abilities of Ukrainian
pharmacological complex and
noted the prospects of the use of
Ukrainian drugs in implementation
of joint projects.
“Establishing cooperation with
Kenya in healthcare, including the
fight against infectious diseases
will promote the expansion of
the Ukrainian pharmaceutical
companies to local markets”, the
press release of the Association
of Ukrainian drug producers
noted.
Earlier, in Mar 2016, Ukrainian
company Interchem participated
in the largest pharmaceutical
exhibition in the West Africa in
Kenya.

7. Page 7
Ukrainian Pharmaceutical Market Monthly: August 2016
HEALTHCARE NEWS
Ulana Suprun filed candidacies of
her deputies
Acting Minister of Healthcare of
Ukraine Ulana Suprun submitted
the candidacies for the posts of
Deputy Heads of the MOH to be
approved by the government. On 1
Aug 2016, during presenting Mrs.
Suprun at her new position, Vice
Premier Minister of Ukraine said
the government gives her carte
blanche on forming her own team.
The candidacies Mrs. Suprun
proposed are following:
Oleksandr Linchevskiy, thoracic
surgeon, who had worked in
district hospital in the ATO zone
then become tactical medicine
instructor.
Oksana Sivak, obstetrician
gynecologist by profession, had
worked as a volunteer doctor at
Maidan. Used to be a coordinator
of public organization Iniciativa E+.
Pavlo Kovtoniuk, main editor of
the magazine “PRO management
in healthcare”, former project
manager for the health care
reform of the National Reform
Council. Currently, Mr. Kovtoniuk
is an expert on healthcare reform
of the WHO.
After her appointment, Ulana
Suprun had had only one Deputy
– Roman Ilyk. On Aug 23, Kyiv
Court of Appeal satisfied the
complaint of the former Deputy
Minister of Healthcare Roman
Vasilishin, who is suspected in
receiving a bribe, and restored
him at the position.
In 1H2016, State Expert Center
received 11 ths notification of
adverse reactions to drugs
In 1H2016, the State Expert
Center of the MOH (SEC) received
10,943 notification of adverse
reactions to drugs. In 2015, the
number of such notifications
amounted 18,864. Herewith,
none of those reports caused the
termination of the registration
certificates for medicinal
products.
In 2015, 51.8% of adverse
reactions were related to
Ukrainian drugs and 15.4% to
Indian drugs.
Ulana Suprun stopped illegal
privatization of 32 health facilities
Acting Minster of Healthcare of
Ukraine Ulana Suprun withdrew
the letter on transfer of 32
health facilities at the regional
level, which had been signed by
former Deputy Minister Viktor
Shafranskiy in July 2016. The
health facilities were supposed
to be transferred to finance
local budgets and subsequently
privatized.
“We received a lot of appeals
from the public and the
institutions themselves in relation
to previously signed letters with
the caveat about the possible
nontransparent privatization and
corrupt schemes,” Mrs. Suprun
said. “The Ministry decided to
stop the process to examine the
situation and make a decision.”
The main achievements in
healthcare in 1H2016 determined
National Reforms Council
determined the main
achievements in healthcare
sphere in Ukraine in 1H2016,
which are:
»» approval of the Law on
simplified registration of drugs,
registered in countries with
strict regulatory system, which
is seen as an important step
for pharmaceutical market
deregulation;
»» approval of the Draft Law on
autonomization of healthcare
organizations (#2309 a-d).
The document is in process of
revision for the second reading
voting;
»» significant progress in the
harmonization of processes
in healthcare reformation and
decentralization. Approval of
the road map of changes in
primary care and establishment
of hospital districts;
»» creation of the working group
at the Cabinet of Ministers of
Ukraine with participation of
the MOH and other Offices
for the implementation of the
program of priority actions of
the government in healthcare
in 2016.
At the same time, the Council is
concerned about the possible
failure to submit the Draft Law
#2309 a-d for the second
reading voting. The working group
made more than 40 amendments,
the most of which were not
supported by the Parliamentary
Committee on Public Health.
Another threat in healthcare is
deceleration of supply of medical
production procured for state
budget.
The Council also determined the
following steps in healthcare
reformation:
»» approval by the government
of the Concept of healthcare
financing reform and the
Concept of public health
reform;
»» approval of the Draft Law
#2309 a-d on autonomization
of healthcare organizations by
the Parliament;
»» revitalization of the process of
the start of procurement cycles
with international organizations.
New Head of State Expert Center
was appointed
On Aug 16, State Enterprise State

8. Page 8
Ukrainian Pharmaceutical Market Monthly: August 2016
Expert Center of the MOH (SEC)
was headed by Tetyana Dumenko,
who replaced Tetyana Talaeva at
the positon. Earlier Mrs. Dumenko
was Director of the Department
of rational pharmacotherapy and
maintaining the state formulary
system of the SEC. On Aug 12, the
MOH fired Mrs. Talaeva because
of “insufficient qualification”.
Deputy Head of the MOH Roman
Ilyk instructed the new Director
of the SEC to submit proposals
for the further development of
the Center, in accordance with the
best European practices.
The SEC is a specialized expert
institution in sphere of pre-clinical
studies, clinical trials and state
registration of drugs, which
is the premier organization in
the field of pharmacovigilance,
standardization of medical care
and health services.
Professional community expects
official recognition of plastic
surgery in Ukraine
Professional community of plastic
surgeons hopes for official
recognition of plastic surgery
specialty in Ukraine, the President
of Ukrainian Association of
Plastic, Reconstructive and
Aesthetic Surgeons (UAPRAS)
Vasil Pinchuk said.
“Juridically there is no plastic
surgery in Ukraine,” Mr. Pinchuk
noted. “A lot of plastic surgeons
do not advertise they do plastic
surgery; they conduct them under
the guise of ordinary operations.
“The shadow market of plastic
surgery in Ukraine is quite large,
but it’s hard to precisely record
the number of plastic surgeries
made, Mr. Pinchuk added.”
The UAPRAS is seeking the
recognition of plastic surgery
specialty in Ukraine to regulate
the activity of plastic surgeons,
implement the licensing
requirements and certification of
specialists.
Wheras, the Secretary of
International Society of Aesthetic
Plastic Surgery (ISAPS) noted the
high level of Ukrainian specialists
in plastic surgery as such
surgeries are in big demand from
foreign patients.

9. Business
Consulting
HR-
Consulting
Market
Access
Business
Education
Support of M&A Deals / Pre-investment Due Diligence
Commercial Audit / Business Diagnostics
FCPA Audit / Reputational Audit
Executive Search / Recuiting
Organizational Consulting / Personnel Assessment
Outplacement
Launch Planning / Marketing Analysis & Planning
Regulatory Environment Audit / Business Modelling
Analysis of Prescribers and Consumers
Business Training for Pharmaceutical Companies:
Strategy / Change Management
New Launches / Marketing
UPharma Consulting is a
professional consulting
company, operating in the
Life Sciences sector. We
deliver best global practices
in market knowledge,
people management,
marketing and strategy in
the CIS/CEE.
UPharma Consulting
21st
Marshal Tymoshenko str.,
building 7, office 5
Kiev, 04212
Ukraine
+380 (44) 232 1142
+380 (44) 232 1143
www.upharma-c.com
mailbox@upharma-c.com
Subscribe to
Upharmacia
instantly!